## Clinical Context: LNG-IUS and Amenorrhea The patient has an **LNG-IUS (levonorgestrel-releasing intrauterine system)** with **amenorrhea** — a common and expected side effect due to endometrial atrophy from chronic progestin exposure. However, the clinical question asks for the **investigation of choice to assess device integrity and position**, not to diagnose the cause of amenorrhea. ## Investigation of Choice: Transvaginal Ultrasound **Key Point:** Transvaginal ultrasound (TVS) is the **gold standard** to confirm correct IUCD positioning, assess endometrial thickness, and detect complications (perforation, malposition, expulsion). ### Why TVS is Indicated in LNG-IUS Users | Clinical Question | TVS Finding | Significance | |-------------------|-------------|---------------| | **Is the device in situ?** | IUCD echo in uterine cavity | Confirms correct position | | **Is there perforation?** | IUCD outside uterus ± free fluid | Surgical emergency | | **Is there malposition?** | IUCD in lower segment or tilted | May ↓ efficacy; consider replacement | | **Endometrial status** | Thin endometrium (2–3 mm) | Expected with LNG-IUS; reassuring | | **Is there expulsion?** | Absence of IUCD | Device failure; needs reinsertion | **High-Yield:** Amenorrhea with an LNG-IUS is **expected and reassuring** (indicates good progestin effect and endometrial suppression). TVS confirms the device is **functioning correctly** and not causing harm. ## Clinical Pearl **Amenorrhea ≠ pathology with LNG-IUS.** Up to 20% of users achieve amenorrhea by 1 year; by 5 years, 40–50% are amenorrheic. This is a **feature, not a bug** — it indicates excellent contraceptive efficacy and reduced menstrual blood loss. However, **device position must always be confirmed** by TVS to rule out silent perforation or expulsion. ## Why Other Investigations Are Not Appropriate See **whyEachDistractorIsWrong** section below. [cite:Park 26e Ch 18]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.